Company overview
Basic information
Company name
Stagmeda, MB
Company code
306732818
VAT code
LT100017397714
Registered address
Alytaus r. sav., Pivašiūnų sen., Pušėnų k. 12, LT-62189
Registration date
2024-04-25
Company age: 2 y. 6 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Not disclosed
(personal)
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
New construction
Ownership form
Private without foreign capital
Stagmeda MB
Company code: 306732818
Address: Alytaus r. sav., Pivašiūnų sen., Pušėnų k. 12, LT-62189
VAT code: LT100017397714
Description
This description was generated by artificial intelligence.
Stagmeda, MB (company code 306732818) is an operational private small partnership, registered on 2024-04-25. It is classified as a micro company in the sector of national private non-financial companies, under private ownership held by Lithuanian natural and legal persons with no foreign investor capital. Governance is listed as CEO only. The company is located at Pušenu k. 12, Pivašiunu sen., Alytaus r. sav., Alytaus apskr. Its main activity is EVRK F.41.00.10, New construction.
In financial terms, the company generated revenue of EUR 158.2K in 2025, up 138.9% from EUR 66.2K in 2024. Net profit was EUR 19.9K in 2025, compared with EUR 22.4K in 2024, while the net profit margin decreased from 33.9% to 12.6%. At the end of 2025, equity stood at EUR 33.5K, liabilities at EUR 19.3K and total assets at EUR 52.8K. Average employment was 1 in both 2024 and 2025; staffing data for 2026 is so far partial.
In financial terms, the company generated revenue of EUR 158.2K in 2025, up 138.9% from EUR 66.2K in 2024. Net profit was EUR 19.9K in 2025, compared with EUR 22.4K in 2024, while the net profit margin decreased from 33.9% to 12.6%. At the end of 2025, equity stood at EUR 33.5K, liabilities at EUR 19.3K and total assets at EUR 52.8K. Average employment was 1 in both 2024 and 2025; staffing data for 2026 is so far partial.
Download a detailed company report
Make confident decisions with all the information about Stagmeda, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.